|Articles|April 1, 2001
- Pharmaceutical Executive-04-01-2001
- Volume 0
- Issue 0
Regulation: Two-Track Plan
Author(s)Kevin Gopal
Brussels-Two types of mutual recognition procedures are necessary to ensure that generics get to market as quickly as possible, according to the European Generics Medicines Association.
Advertisement
Articles in this issue
over 24 years ago
Internet DTC - Minding Your P's & Q'sover 24 years ago
Policy: Tectonic Shiftover 24 years ago
Liberated?over 24 years ago
A Matter of Tasteover 24 years ago
Partnerships: Bargaining Biotechsover 24 years ago
Pediatric Mandateover 24 years ago
Genentech's Passion for Patientsover 24 years ago
Regulation: OK After AllNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
4
FDA Announces New Biosimilar-Targeted Draft Guidance
5
